23 studies found for:    Open Studies | "Gout"
Show Display Options
Rank Status Study
1 Recruiting Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
Condition: Gout
Interventions: Drug: PF-06743649;   Other: Placebo
2 Unknown  Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout
Conditions: Hyperuricemia;   Gout
Intervention: Drug: levotofisopam
3 Recruiting Arthritis Research UK Gout Treatment Trial - Phase 2
Condition: Gout
Interventions: Other: Nurse intervention;   Other: Standard care
4 Not yet recruiting Colchicine Or Naproxen Treatment for ACute gouT
Condition: Gout
Interventions: Drug: Low-dose colchicine;   Drug: Naproxen
5 Not yet recruiting RDEA3170 and Allopurinol Combination Study in Gout Subjects
Condition: Gout
Interventions: Drug: RDEA3170 10 mg;   Drug: allopurinol 300 mg
6 Recruiting RDEA3170 and Febuxostat Combination Study in Gout Subjects
Condition: Gout
Interventions: Drug: RDEA3170 15 mg;   Drug: RDEA3170 10 mg;   Drug: RDEA3170 2.5;   Drug: RDEA3170 5 mg;   Drug: Febuxostat 40 mg;   Drug: Febuxostat 80 mg
7 Recruiting The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
Conditions: Antiphospholipid Syndrome;   Endothelial Dysfunction;   Hyperuricemia;   Gout;   Metabolic Syndrome
Intervention:
8 Recruiting Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
Condition: Gout
Interventions: Drug: Febuxostat IR;   Drug: Febuxostat XR;   Drug: Febuxostat placebo;   Drug: Colchicine;   Drug: Naproxen;   Drug: Lansoprazole
9 Recruiting Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients
Condition: Gout
Interventions: Drug: Arhalofenate 600 mg;   Drug: Allopurinol 300 mg;   Drug: Colchicine 0.6 mg;   Drug: Placebo;   Drug: Arhalofenate 800 mg
10 Recruiting Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
Conditions: Gout;   Hyperuricemia
Interventions: Drug: Arhalofenate;   Drug: Febuxostat;   Drug: Colchicine
11 Recruiting Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
Conditions: Gout;   Moderate Renal Impairment
Interventions: Drug: Febuxostat IR;   Drug: Febuxostat XR;   Drug: Febuxostat placebo;   Drug: Colchicine;   Drug: Naproxen;   Drug: Lansoprazole
12 Recruiting Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Condition: Chronic Gout
Intervention: Biological: pegloticase
13 Recruiting Rheumatology Informatics System for Effectiveness
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Gout
Intervention:
14 Recruiting Impact of Unapproved Drug Initiative on Colchicine Use
Condition: Gout
Intervention:
15 Recruiting Purine Metabolism Enzyme SNP to Uric Acid Production
Conditions: Gout;   Hyperuricemia
Intervention:
16 Recruiting Effects of Fasting on Self Efficacy
Conditions: Chronic Pain;   Fibromyalgia;   Rheumatoid Arthritis;   Gout;   Headache;   Arthritis;   Gastrointestinal Diseases;   Irritable Bowel Syndrome;   Inflammatory Bowel Disease;   Cardiovascular Diseases
Intervention: Behavioral: Fasting
17 Recruiting Hereditary Tubulointerstitial Nephritis
Conditions: Nephritis, Interstitial;   Chronic Renal Failure;   Gout;   Renal Cysts
Intervention: Other: Blood and urine sample collections
18 Recruiting Mild, Moderate and Severe Renal Impairment Study
Condition: Gout
Intervention: Drug: RDEA3170
19 Unknown  Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
Condition: Gout
Intervention: Drug: Febuxostat
20 Unknown  Safety and Efficacy Study of Intramuscular Uricase-PEG 20
Conditions: Gout;   Hyperuricemia
Intervention: Biological: Uricase-PEG 20

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Indicates status has not been verified in more than two years